Lebanon, United States
DoseOptics LLC, founded in 2015, operates within the Health Care sector and is headquartered in the United States. The company is pioneering advancements in radiation therapy with its flagship product, BeamSite. This unique system is distinguished as the only system capable of capturing real-time video imaging of radiotherapy dose delivery through Cherenkov light emissions. This innovation plays a critical role in enhancing patient safety and ensuring the quality of radiation therapy, aligning perfectly with the company’s slogan: "Creating systems to visualize radiotherapy in real-time. Every patient. Every fraction. Seeing is believing..."
The company's last known investment was a $2.00M Seed Round on 01 October 2016, led by the National Institutes of Health. As a frontrunner in healthcare technology, DoseOptics LLC represents a solid investment opportunity due to its groundbreaking approach to radiation therapy visualization.
